{
  "success": true,
  "pagesUsed": [
    3,
    9,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    23,
    34,
    57
  ],
  "modelUsed": "gemini-2.5-pro",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Screening Window",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "relativeTo": "Randomization",
        "windowLower": -28,
        "windowUpper": -2
      },
      {
        "id": "timing_2",
        "name": "Washout Period",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "relativeTo": "Previous Visit",
        "windowLower": 3,
        "windowUpper": 14
      },
      {
        "id": "timing_3",
        "name": "Follow-up Visit Window",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 28,
        "relativeTo": "Last Dose",
        "windowLower": -2,
        "windowUpper": 2
      },
      {
        "id": "timing_4",
        "name": "CRU Discharge",
        "type": "After",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 6,
        "relativeTo": "Last Dose",
        "windowLower": 6
      },
      {
        "id": "timing_5",
        "name": "Study Drug Administration Timing",
        "type": "After",
        "unit": "minutes",
        "instanceType": "Timing",
        "value": 5
      },
      {
        "id": "timing_6",
        "name": "Additional Follow-up Visit Interval",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 84,
        "relativeTo": "Previous Visit",
        "windowLower": -7,
        "windowUpper": 7
      },
      {
        "id": "timing_7",
        "name": "Unscheduled Antibody Sample Post-Hypersensitivity",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 30,
        "windowLower": 0,
        "windowUpper": 0
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "Admission Rescheduling Condition",
        "instanceType": "Condition",
        "description": "Condition for rescheduling admission to the CRU on Day 1.",
        "text": "Plasma Glucose (PG) level is not between 90 and 250 mg/dL on Day 1."
      },
      {
        "id": "cond_2",
        "name": "Stop Insulin Infusion Condition",
        "instanceType": "Condition",
        "description": "Condition to stop the insulin infusion used to induce hypoglycemia.",
        "text": "Bedside Plasma Glucose (PG) is <60 mg/dL."
      },
      {
        "id": "cond_3",
        "name": "TE ADA Positive Condition",
        "instanceType": "Condition",
        "description": "Condition for triggering additional follow-up.",
        "text": "Patient has treatment-emergent antidrug antibodies (TE ADA) at the follow-up/early discontinuation visit."
      },
      {
        "id": "cond_4",
        "name": "End of Additional Follow-up Criteria",
        "instanceType": "Condition",
        "description": "Criteria to stop the additional follow-up for TE ADA.",
        "text": "Titer returns to baseline (within a single 2-fold dilution of the baseline titer) or 1 year has passed since the last dose of study treatment."
      },
      {
        "id": "cond_5",
        "name": "Interim Safety Review Trigger",
        "instanceType": "Condition",
        "description": "A safety review is conducted after a specific number of patients complete Period 2.",
        "text": "Safety data will be reviewed after the first 6 patients are administered LY900018 in Period 2."
      },
      {
        "id": "cond_6",
        "name": "Study Continuation Post-Safety Review",
        "instanceType": "Condition",
        "description": "Condition to continue dosing after the interim safety review.",
        "text": "No clinically significant safety findings for treatment or study procedure are noted in the first 6 patients."
      },
      {
        "id": "cond_7",
        "name": "Study Stopping Rule",
        "instanceType": "Condition",
        "description": "The entire study may be stopped based on the interim safety review.",
        "text": "Study will be stopped if deemed necessary for patient safety following the review of safety data from the first 6 patients to complete Period 2 Day 1."
      },
      {
        "id": "cond_8",
        "name": "Patient Replacement Criteria",
        "instanceType": "Condition",
        "description": "Condition for replacing a discontinued patient.",
        "text": "If patients discontinue from the study before completion of both periods with evaluable primary outcome for any reason, the patient may be replaced."
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Screening to Treatment Transition",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_screening",
        "toElementId": "epoch_treatment",
        "text": "Eligible patients who have provided informed consent will be randomized on Day 1 of Period 1."
      },
      {
        "id": "trans_2",
        "name": "Period 1 to Period 2 Transition",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_period1",
        "toElementId": "epoch_period2",
        "text": "After a washout period of 3 to 14 days, patients proceed from Period 1 to Period 2."
      },
      {
        "id": "trans_3",
        "name": "Transition to Additional Follow-up",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_followup",
        "toElementId": "epoch_additional_followup",
        "text": "Patients with TE ADA at follow-up/ED will undergo additional follow-up."
      },
      {
        "id": "trans_4",
        "name": "Handling of Inadvertently Enrolled Patients",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "If a patient did not meet enrollment criteria, documented approval from the sponsor is required for the patient to continue in the study."
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Completion of all protocol-required visits, including the final follow-up visit."
      },
      {
        "id": "exit_2",
        "name": "Discontinuation by Patient Decision",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The patient, or legal representative, requests to be withdrawn from the study."
      },
      {
        "id": "exit_3",
        "name": "Discontinuation by Investigator Decision",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The investigator decides that the patient should be discontinued from the study for any reason."
      },
      {
        "id": "exit_4",
        "name": "Discontinuation due to Other Study",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Enrollment in any other clinical study involving an investigational product or other incompatible medical research."
      },
      {
        "id": "exit_5",
        "name": "Discontinuation for Medical/Safety/Regulatory Reasons",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participation needs to be stopped for medical, safety, regulatory, or other reasons consistent with applicable laws, regulations, and good clinical practice."
      },
      {
        "id": "exit_6",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A patient repeatedly fails to return for scheduled visits and is unable to be contacted by the study site."
      },
      {
        "id": "exit_7",
        "name": "Study Discontinuation for Safety",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "The entire study is stopped for patient safety reasons based on the interim safety review of the first 6 patients."
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "Admission Decision",
        "timepointId": "Day 1 (Periods 1 and 2)",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point to proceed with or reschedule admission based on PG levels.",
        "conditionIds": [
          "cond_1"
        ]
      },
      {
        "id": "dec_2",
        "name": "Interim Safety Review Decision",
        "timepointId": "After first 6 patients complete Period 2",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point to continue or stop the study based on safety data from the initial cohort.",
        "conditionIds": [
          "cond_5",
          "cond_6",
          "cond_7"
        ]
      },
      {
        "id": "dec_3",
        "name": "Additional Follow-up Decision",
        "timepointId": "Follow-up/ED Visit",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Decision point to initiate additional follow-up based on TE ADA results.",
        "conditionIds": [
          "cond_3"
        ]
      }
    ],
    "summary": {
      "timingCount": 7,
      "conditionCount": 8,
      "transitionRuleCount": 4,
      "exitCount": 7
    }
  }
}